Alzheimer Europe is pleased to announce that the call for abstracts for the 27th Alzheimer Europe Conference (27AEC), in Berlin from 2 to 4 October, is now open.
This year, Association Luxembourg Alzheimer (ALA) celebrates its 30th birthday, as well as 25 years of the Fondation Alzheimer and 10 years since its nursing home opened.
AE has added another clinical trial to its Clinical Trials Watch service: Hoffmann-La Roche’s CREAD study. The study is investigating Crenezumab as a treatment for AD.
This newsletter received funding under an operating grant from the European Union’s Health Programme (2014-2020).
The content of this newsletter represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.
Alzheimer Europe’s 
This newsletter received funding under an operating grant from the European Union’s Health Programme (2014-2020).